Sat.Jan 15, 2022 - Fri.Jan 21, 2022

GSK loses R&D chief Barron to high-powered startup amid investor pressure

Bio Pharma Dive

Hal Barron, a key figure in GSK's efforts to revitalize its drug research, will step down as its top scientist at a time when the company is feeling heat from investors to deliver faster growth

Can pharma really leverage social media?

World of DTC Marketing

A Mediabistro survey showed that social networks influence more than 40% of people’s health choices. Tik-Tok, Instagram, and other social media channels may soon be overwhelmed with pharma companies’ content, but is it a good idea?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Surprised by a Medical Bill? Here’s What to Do.

Triage Cancer

If you’ve ever been surprised by a medical bill, you’re not alone. An estimated 10 million patients a year receive the shock of unexpectedly high medical bills for emergency or out-of-network care from providers they did not choose.

Mange outbreak decimated a wild vicuña population in Argentina

Scienmag

Mange has decimated the population of wild vicuñas and guanacos in an Argentinian national park that was created to conserve them, according to a study from the Administration of National Parks in Argentina and the University of California, Davis.

83

2022 Research: The Rapid Rise of Ocean Freight Visibility

Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.

Roche sees cause for optimism with failed Huntington's disease drug. Others aren't so sure.

Bio Pharma Dive

After halting a Phase 3 trial of the drug last year, Roche went digging for more data. What it found led to plans for another trial, but the pharma's hypothesis may rest on shaky ground

Trials 272

More Trending

ililli: How Social Audio is Driving HCP Engagement

Pharma Marketing Network

Talk to me. Pharma brands that want deep engagements need to look at and listen to social audio. It’s not surprising. In fact, it’s the most direct route to your goal. You want to talk to doctors?

NASA Emergency Beacons Save Lives in 2021

Scienmag

In 2021, NASA technology saved 330 lives in the U.S. network region of the international satellite-aided search and rescue effort, Cospas-Sarsat. NASA has lent technical expertise to the Cospas-Sarsat program since its founding, aiding in the rescue of over 48,000 individuals globally.

Bluebird faces longer wait for FDA verdict on experimental gene therapies

Bio Pharma Dive

The FDA has extended by three months its review of Bluebird's treatments for beta thalassemia and a rare brain disorder, the latest delay in the company's lengthy road to market in the U.S.

Horizon pharma’s bad DTC decision

World of DTC Marketing

Thyroid eye disease affects more women than men, although men are more likely to have severe illnesses. The exact prevalence of thyroid eye disease is not known, but is estimated to be 16 per 100,000 women in the general population, and 2.9 per 100,000 men in the general population.

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.

Which PCD Products Are The Best To Start A Pharma Franchise?

Fossil Remedies

We know that the PCD Pharma Franchise business is lucrative and profitable. But do we know which PCD products should we pick so that the maximum profitability is ensured? Perhaps no. This blog is an attempt to clarify the concepts about choosing the best products. First, choose the right company.

Research finds patients and providers differ in opinions about immediate access to medical records

Scienmag

While both patients and clinicians prioritize information transparency, a 21st Century Cures Act requirement for the immediate release of test and lab results is proving more controversial, according to recently published survey results of clinicians and patients.

UCB to buy Zogenix for nearly $2B in 'first step' for M&A in 2022

Bio Pharma Dive

The acquisition will give the Belgian pharma access to an epilepsy drug that won U.S. approval in June 2020 but that Zogenix has struggled to sell

Drugs 247

Omnichannel is irrelevant with the wrong message

World of DTC Marketing

Omnichannel is the latest buzzword-making rounds within pharma, but omnichannel has no relevance if your message is too promotional or is irrelevant to your audience. The channel IS essential but not as important as your message.

Mandatory COVID Vaccination Policy Template

The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.

Vir Biotechnology and Bill & Melinda Gates Foundation to develop vaccinal antibody tech for tackling HIV and malaria

BioPharma Reporter

Vir Biotechnology and the Bill & Melinda Gates Foundation have partnered up to develop broadly neutralizing antibodies designed to provide a âvaccinal effectâ for the treatment of HIV and prevention of malaria. Bio Developments

Sidewinding young stellar jets spied by Gemini South

Scienmag

Sinuous stellar jets meander lazily across a field of stars in new images captured from Chile by the international Gemini Observatory, a Program of NSF’s NOIRLab.

83

Top Merck executive to depart company for CEO role at ingredients maker

Bio Pharma Dive

Frank Clyburn, a Merck veteran and head of the company's human health division, will leave next month to run IFF, following the exit of other top leaders at the drugmaker

244
244

How digital patient recruitment can reduce enrollment costs in Major Depressive Disorder clinical trials

Clairnes

The post How digital patient recruitment can reduce enrollment costs in Major Depressive Disorder clinical trials appeared first on Clinical Trial Recruitment & Management Services. Blog clinical trial patient recruitment decentralized trials hybrid trials patient centricity regulation changes

Novo Nordisk moves to strengthen obesity efforts

Pharma Phorum

After securing FDA approval for Wegovy last year, Novo Nordisk is strengthening its position in the obesity space through a collaboration with EraCal Therapeutics.

Ley, Hedrick to lead new MCG Center for Immunology

Scienmag

Renowned immunologists and vascular biologists Drs.

EQRx builds case for cancer drug it hopes can disrupt market

Bio Pharma Dive

Study results show EQRx's drug, which it means to position as a lower-cost alternative to widely used cancer immunotherapies, extended the lives of lung cancer patients. But it's unclear whether that will be enough to sway the FDA

Lab data show Valneva vaccine effective against Omicron

BioPharma Reporter

Valneva announced yesterday that results from a lab study showed three doses of its inactivated COVID-19 vaccine candidate, VLA2001, neutralized the Omicron variant. Markets & Regulations

Billionaire-backed “rejuvenation” start-up Altos Labs launches operations

Pharma Phorum

Just months after the venture was unveiled, controversial biotechnology company Altos Labs has officially launched with $3 billion in funding secured from investors.

How scientists tested the supersonic dynamic characteristics of Tianwen-1 Mars Entry Capsule?

Scienmag

The Tianwen-1 Mars entry capsule successfully landed on the surface of Mars in southern Utopia planitia on May 14th, 2021 at 23:18 UTC. One of the biggest challenges is that a typical blunt body such as Tianwen-1 Mars entry capsule suffers dynamic instability in supersonic regime.

Roche revives a closely watched Huntington's disease drug

Bio Pharma Dive

Ten months after Roche stopped giving the drug to patients in a Phase 3 trial, the pharma is planning a new study on the belief the medicine may help younger adult patients with less advanced disease

Trials 233

Beximco Pharma to manufacture molnupiravir for COVID-19

Pharma Times

The drug received conditional marketing authorisation in the UK from the MHRA in November

GSK rejects $68.4bn Unilever bid for consumer health

Pharma Phorum

GlaxoSmithKline (GSK) claims it has rejected three unsolicited, conditional and non-binding proposals from Unilever to acquire GSK Consumer Healthcare in a deal worth approximately $68.4 billion (£50 billion).

Sales 96

A new digital gap in internet usage between rich and poor people has been detected

Scienmag

Social networks are used more often in poor neighbourhoods than in affluent neighbourhoods, while the latter tend to consume more information from traditional online media.

FDA approves AbbVie, Pfizer drugs for eczema, creating competition for Sanofi

Bio Pharma Dive

AbbVie's Rinvoq and Pfizer's Cibinqo are both JAK-inhibiting drugs that are taken orally, a convenience which could help them compete against injectable treatments like Sanofi and Regeneron's Dupixent

Will new Facebook ad policy shake up clinical trial recruitment?

Outsourcing Pharma

An expert from patient solutions firm Trialbee discusses how the social media firm's recent ban on targeted advertising might impact patient recruitment. Patient centricity

Covid vaccine booster raises antibody levels in fight against Omicron

Pharma Phorum

A third dose of vaccine has been shown to effectively neutralise the Omicron variant of covid-19, according to researchers. Research led by UCLH, UCL and the Francis Crick Institute found that the booster dose successfully stimulates antibody levels that neutralise Omicron.

Will prescription diets treat and prevent chronic disease?

Scienmag

BATON ROUGE, Louisiana – A new federally funded study will use machine learning to predict how an individual responds to a given diet, allowing physicians to offer patients personalized nutrition prescriptions to improve health and treat chronic diseases.